LL
INSIDER · KROS · Keros Therapeutics, Inc. · CHIEF SCIENTIFIC OFFICER
Lerner Lorena Raquel
Every open-market transaction filed under this name, Aug 18 to Aug 18.
Filings
1
0 buys · 1 sell
Bought
—
open market, at cost
Sold
$37K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Aug 18 | KROS | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,568 | $10.29 | $37K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.